« back to

March 1, 2018

2018 NIH Alzheimer’s Research Summit

Michela Gallagher will participate in a session on “Emerging Therapeutics” to discuss AgeneBio’s Programs targeting hippocampal hyperactivity in the Mild Cognitive Impairment phase of prodromal Alzheimer’s disease.